Barlow Wealth Partners Inc. Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Barlow Wealth Partners Inc. acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 31,616 shares of the healthcare conglomerate’s stock, valued at approximately $16,645,000. UnitedHealth Group makes up about 2.4% of Barlow Wealth Partners Inc.’s investment portfolio, making the stock its 13th biggest position.

A number of other hedge funds also recently made changes to their positions in UNH. Crestone Asset Management LLC lifted its holdings in shares of UnitedHealth Group by 5.4% in the 4th quarter. Crestone Asset Management LLC now owns 471 shares of the healthcare conglomerate’s stock worth $248,000 after acquiring an additional 24 shares during the last quarter. Patrick M Sweeney & Associates Inc. acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $1,025,000. Sovereign Financial Group Inc. increased its stake in UnitedHealth Group by 6.3% during the 4th quarter. Sovereign Financial Group Inc. now owns 2,078 shares of the healthcare conglomerate’s stock valued at $1,094,000 after purchasing an additional 124 shares in the last quarter. Simmons Bank boosted its holdings in shares of UnitedHealth Group by 11.6% in the 4th quarter. Simmons Bank now owns 10,795 shares of the healthcare conglomerate’s stock valued at $5,683,000 after acquiring an additional 1,123 shares during the last quarter. Finally, Centric Wealth Management raised its position in UnitedHealth Group by 5.1% during the fourth quarter. Centric Wealth Management now owns 6,966 shares of the healthcare conglomerate’s stock valued at $3,504,000 after acquiring an additional 338 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $2.25 during mid-day trading on Wednesday, reaching $503.21. 2,942,905 shares of the stock were exchanged, compared to its average volume of 4,362,104. The firm has a 50-day simple moving average of $481.45 and a 200 day simple moving average of $511.98. The company has a market cap of $462.99 billion, a price-to-earnings ratio of 30.62, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the business earned $6.26 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on UNH shares. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, TD Cowen decreased their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.